Status:
TERMINATED
Expectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical Trial
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Conditions:
HIV Seropositivity
Eligibility:
All Genders
18-65 years
Brief Summary
Following the ANRS-APSEC survey, AMEP-EHVA T02 is a longitudinal social science study that will explore the experience of people living with HIV (PLWH) who were offered to participate in the European ...
Detailed Description
Moving towards the discovery of an HIV cure is of major public health interest, not only for people living with HIV (PLWH) who currently must take lifelong antiretroviral treatment (ART), with its ass...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- people living with HIV
- who were offered to participate in EHVA T02 clinical trial
Exclusion
Key Trial Info
Start Date :
June 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2023
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT05280392
Start Date
June 21 2022
End Date
March 30 2023
Last Update
May 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUV
Lausanne, Switzerland